BCAR1P2

Across TCGA pan-cancer cohorts, BCAR1P2 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated BCAR1P2 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher BCAR1P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated BCAR1P2 expression acts as an unfavorable survival marker.

LUSC, LIHC, and LUAD are the cancer types where BCAR1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	III,IV	0.010	0.754	<.001	99	view →
LIHC	DFS	Tertile	All	0.244	0.551	.001	81	view →
LUAD	OS	Tertile	All	0.307	0.678	.019	36	view →
BLCA	DFS	Tertile	III,IV	0.180	0.578	<.001	21	view →
HNSC	OS	Tertile	All	0.535	0.727	.015	21	view →
LAML	DFS	Tertile	All	0.126	0.578	.005	18	view →
KIRP	OS	Tertile	III,IV	0.111	0.697	<.001	18	view →
SKCM	DFS	Tertile	All	0.470	0.772	.007	9	view →
KIRC	DFS	Tertile	II,III,IV	0.549	0.771	.034	6	view →
ESCA	OS	Tertile	All	0.586	1.000	.040	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

BCAR1P2–LUSC (DFS)

Open the LUSC breakdown →